AU2001236817A1 - Insulin homolog polypeptide zins4 - Google Patents

Insulin homolog polypeptide zins4

Info

Publication number
AU2001236817A1
AU2001236817A1 AU2001236817A AU3681701A AU2001236817A1 AU 2001236817 A1 AU2001236817 A1 AU 2001236817A1 AU 2001236817 A AU2001236817 A AU 2001236817A AU 3681701 A AU3681701 A AU 3681701A AU 2001236817 A1 AU2001236817 A1 AU 2001236817A1
Authority
AU
Australia
Prior art keywords
zins4
homolog polypeptide
insulin homolog
insulin
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001236817A
Inventor
James L. Holloway
Stephen R. Jaspers
Si Lok
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zymogenetics Inc
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of AU2001236817A1 publication Critical patent/AU2001236817A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6454—Dibasic site splicing serine proteases, e.g. kexin (3.4.21.61); furin (3.4.21.75) and other proprotein convertases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/64—Relaxins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2001236817A 2000-03-10 2001-02-09 Insulin homolog polypeptide zins4 Abandoned AU2001236817A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52334600A 2000-03-10 2000-03-10
US09523346 2000-03-10
PCT/US2001/004199 WO2001068862A1 (en) 2000-03-10 2001-02-09 Insulin homolog polypeptide zins4

Publications (1)

Publication Number Publication Date
AU2001236817A1 true AU2001236817A1 (en) 2001-09-24

Family

ID=24084640

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001236817A Abandoned AU2001236817A1 (en) 2000-03-10 2001-02-09 Insulin homolog polypeptide zins4

Country Status (5)

Country Link
EP (1) EP1294887A1 (en)
JP (1) JP2003526373A (en)
AU (1) AU2001236817A1 (en)
CA (1) CA2402614A1 (en)
WO (1) WO2001068862A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7049403B2 (en) 2000-04-21 2006-05-23 Takeda Pharmaceutical Company Limited Insulin/IGF/relaxin family polypeptides and DNAS thereof
AUPR814401A0 (en) 2001-10-08 2001-11-01 Howard Florey Institute Of Experimental Physiology And Medicine Human 3 relaxin
EP1636384A4 (en) * 2003-06-20 2007-03-07 Amgen Inc Gene amplification and overexpression in cancer
KR100878959B1 (en) * 2004-02-09 2009-01-19 에자이 알앤드디 매니지먼트 가부시키가이샤 Screening method
US7893197B2 (en) 2004-08-25 2011-02-22 Janssen Pharmaceutica N.V. Relaxin-3 chimeric polypeptides and their preparation and use
WO2006026355A2 (en) * 2004-08-25 2006-03-09 Janssen Pharmaceutica N.V. Relaxin-chimeric polypeptides and their preparation and use
EP2129359B1 (en) * 2007-01-30 2012-03-14 Janssen Pharmaceutica, N.V. Chimeric peptide antagonist for gpcr135 or gpcr142

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0918859A1 (en) * 1996-08-02 1999-06-02 ZymoGenetics, Inc. Testis-specific insulin homolog polypeptides
WO1998016635A1 (en) * 1996-10-15 1998-04-23 Zymogenetics, Inc. Insulin homologs
AU5530198A (en) * 1996-12-16 1998-07-15 Zymogenetics Inc. Compositions and methods for stimulating pancreatic islet cell regeneration

Also Published As

Publication number Publication date
CA2402614A1 (en) 2001-09-20
JP2003526373A (en) 2003-09-09
EP1294887A1 (en) 2003-03-26
WO2001068862A1 (en) 2001-09-20

Similar Documents

Publication Publication Date Title
AU2631001A (en) Novel fgf homolog zfgf11
AU2919001A (en) Syringe
AU2001274548A1 (en) Syringe
AU2001278755A1 (en) Injections
AU2759201A (en) Novel fgf homolog zfgf12
AU2001259837A1 (en) Therapeutic pore-forming peptides
AU2001236817A1 (en) Insulin homolog polypeptide zins4
AU5706000A (en) Useful polypeptide
AU1541601A (en) Syringes
GB0015761D0 (en) Polypeptide
AU2001260236A1 (en) Restricted use syringe
HK1053062A1 (en) Pernasally absorbable insulin preparations
AU4778600A (en) Novel polypeptide
AU2232399A (en) Recombinant ctb-based vaccines
AU2001278975A1 (en) Alpha-conotoxin peptides
GB0120704D0 (en) Polypeptide
AU2002224056A1 (en) Novel polypeptide
AU2001234855A1 (en) Neuropeptide-like polypeptide zpep17
AU4351900A (en) Inducible vaccines
GB0008877D0 (en) Polypeptide delivery system
AU2463401A (en) Novel fgf homolog zfgf10
AU2001248954A1 (en) Iscom polypeptide delivery system
AUPR223600A0 (en) Antigenic polypeptide
AUPQ425799A0 (en) Antigenic polypeptide
GB0013239D0 (en) Polypeptide